You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lymphoproliferative disorder

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Post-transplant Lymphoproliferative Disorder Trial in Saint Louis (Polatuzumab vedotin, Rituximab, CHP)

Not yet recruiting
  • Post-transplant Lymphoproliferative Disorder
  • Polatuzumab vedotin
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 9, 2023

Post-transplant Lymphoproliferative Disorder Trial in Cleveland (Rituximab, Acalabrutinib, CT scans)

Active, not recruiting
  • Post-transplant Lymphoproliferative Disorder
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Jan 16, 2023

Study of Autoimmune Lymphoproliferative Syndrome (ALPS)

Recruiting
  • Benign Lymphoproliferative Disorder
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Liquid Biopsy to Enable Diagnostics and Monitoring for

    Recruiting
    • Lymphoproliferative Disorders
    • Lymphoproliferative Disorder Following Transplantation
    • Liquid biopsy
    • Basel, Switzerland
    • +5 more
    Mar 24, 2023

    Recurrent Lymphoproliferative Disorder, Refractory Lymphoproliferative Disorder Trial in Duarte (Leflunomide)

    Active, not recruiting
    • Recurrent Lymphoproliferative Disorder
    • Refractory Lymphoproliferative Disorder
    • Duarte, California
      City of Hope Medical Center
    Jun 7, 2022

    Epstein-Barr Virus Infections, Lymphoma, Lymphoproliferative Disorder Trial run by the NCI (Nivolumab)

    Recruiting
    • Epstein-Barr Virus Infections
    • +3 more
    • Nivolumab
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 24, 2023

    Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder, Polymorphic Post-Transplant Lymphoproliferative Disorder Trial

    Not yet recruiting
    • Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder
    • Polymorphic Post-Transplant Lymphoproliferative Disorder
    • Biopsy
    • +5 more
    • New Brunswick, New Jersey
    • +2 more
    Mar 23, 2023

    Epstein-Barr Virus Infection moniToring in renAl Transplant

    Recruiting
    • EBV Infection
    • +3 more
    • EBV DNA in whole blood and plasma
    • Aarhus, Central Region Denmark, Denmark
    • +2 more
    Dec 12, 2022

    Lymphoma Trial in Stanford (rituximab)

    Completed
    • Lymphoma
    • rituximab
    • Stanford, California
      Stanford University Medical Center
    May 25, 2022

    Accuracy Evaluation of the IdentiClone Dx IGH Assay

    Not yet recruiting
    • B-Cell Lymphoproliferative Disorder
    • IdentiClone Dx IGH (IC IGH Dx) Assay
    • San Diego, California
    • +2 more
    Oct 30, 2023

    Lymphomatoid Granulomatosis, Granulomatosis, Lymphomatoid, Non-Hodgkins Lymphoma Trial run by the NCI (Interferon, Rituxan and

    Recruiting
    • Lymphomatoid Granulomatosis
    • +3 more
    • Interferon
    • Rituxan and EPOCH
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    Post-Transplant Lymphoproliferative Disorder, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent DLBCL Trial in Seattle

    Not yet recruiting
    • Post-Transplant Lymphoproliferative Disorder
    • +10 more
    • Loncastuximab Tesirine
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jul 6, 2022

    Early Detection of Epstein-Barr Virus Related Disease.

    Active, not recruiting
    • Post-transplant Lymphoproliferative Disorder
    • +8 more
      • Aarhus, Central Region Of Denmark, Denmark
        Aarhus University Hospital
      Dec 12, 2022

      Waldenstrom Macroglobulinemia, B-Cell Lymphoproliferative Disorder Trial in Boston (Pirtobrutinib, Venetoclax, Allopurinol)

      Not yet recruiting
      • Waldenstrom Macroglobulinemia
      • B-Cell Lymphoproliferative Disorder
      • Boston, Massachusetts
      • +2 more
      Feb 18, 2023

      Lymphoproliferative Disorder, HHV-8, Malignancy Trial run by the National Cancer Institute (NCI) (Etoposide, Interferon-alpha,

      Active, not recruiting
      • Lymphoproliferative Disorder
      • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 24, 2022

      Epstein-Barr Virus Infections, Post-Transplant Lymphoproliferative Disorder, Lymphoma Trial in Montreal (Group A, Group B)

      Recruiting
      • Epstein-Barr Virus Infections
      • +2 more
      • Group A
      • Group B
      • Montreal, Quebec, Canada
        Hôpital Maisonneuve-Rosemont
      Apr 5, 2022

      T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

      Recruiting
      • T-cell Lymphoma
      • +30 more
      • Optional Blood Sample
      • Optional Nail Sample
      • Duarte, California
      • +25 more
      Jul 28, 2023

      Epstein-Barr Virus Infections Trial in Strasbourg (Rituximab, control group)

      Recruiting
      • Epstein-Barr Virus Infections
      • Strasbourg, France
        Les Hôpitaux Universitaires de Strasbourg
      Dec 7, 2021

      Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit (3'-deoxy-3'-[18F]fluorothymidine)

      Recruiting
      • Brain and Central Nervous System Tumors
      • +8 more
      • 3'-deoxy-3'-[18F]fluorothymidine
      • Detroit, Michigan
        Barbara Ann Karmanos Cancer Institute
      Mar 30, 2022

      LGLL - Large Granular Lymphocytic Leukemia, Primary Cutaneous T-Cell Lymphoma - Category, Primary Cutaneous CD8-Positive

      Recruiting
      • LGLL - Large Granular Lymphocytic Leukemia
      • +13 more
      • Duarte, California
      • +9 more
      Aug 9, 2022

      Posttransplant Lymphoproliferative Disorder Trial in Germany (Rituximab sc, Rituximab sc consolidation, Rituximab sc combined

      Completed
      • Posttransplant Lymphoproliferative Disorder
      • Rituximab sc
      • +3 more
      • Aachen, Germany
      • +17 more
      Aug 22, 2022

      Immune Deficiency Disorders, Severe Combined Immunodeficiency, Chronic Granulomatous Disease Trial in Saint Louis (Transplant

      Recruiting
      • Immune Deficiency Disorders
      • +13 more
      • Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan
      • Saint Louis, Missouri
        Washington University
      Apr 25, 2022

      Tissue, Blood, and Body Fluid Sample Collection From Hematologic

      Recruiting
      • Chronic Myeloproliferative Disorders
      • +7 more
      • biologic sample preservation procedure
      • cytology specimen collection procedure
      • Chapel Hill, North Carolina
        Lineberger Comprehensive Cancer Center at University of North Ca
      Oct 14, 2021

      Collecting and Storing Blood Samples From Patients With Cancer

      Withdrawn
      • Brain and Central Nervous System Tumors
      • +10 more
        • (no location specified)
        Sep 20, 2021

        Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma Trial in Atlanta (drug, biological,

        Recruiting
        • Grade 1 Follicular Lymphoma
        • +7 more
        • Atlanta, Georgia
          Emory University Hospital/Winship Cancer Institute
        Dec 7, 2021